ESC 365 - Panel discussion.

ESC Premium Access

Panel discussion.

Session: Hot Line: Late-Breaking Clinical Trials 3

Topic: Valvular heart disease, other

Event: ESC Congress 2017

Congress Presentation

Add to my library

14 more presentations in this session

Naturally randomized 'REVEAL' trial

Speaker: Professor B. Ference (Cambridge, GB)

Discussant review: A Naturally Randomized Trial Comparing the Effect of Genetic Variants that Mimic CETP Inhibitors and Statins on the Risk of Cardiovascular Disease

Speaker: Professor B. Nordestgaard (Copenhagen, DK)

Panel discussion.

Effect of Sildenafil on Clinical Outcomes in Patients with Corrected Valvular Heart Disease and Residual Pulmonary Hypertension.

Speaker: Doctor J. Bermejo Thomas (Madrid, ES)

Discussant review: Effect of Sildenafil on Clinical Outcomes in Patients with Corrected Valvular Heart Disease and Residual Pulmonary Hypertension.

Speaker: Professor I. Lang (Vienna, AT)

Access the full session

Hot Line: Late-Breaking Clinical Trials 3

Speakers: Professor B. Ference, Professor B. Nordestgaard, Doctor J. Bermejo Thomas, Professor I. Lang

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources